These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1510138)

  • 21. [Role of the blood kallikrein-kinin system in activating hemodynamic effects induced by L-thyroxine].
    Kiselev VI; Treshutin VA
    Probl Endokrinol (Mosk); 1982; 28(1):78-81. PubMed ID: 6917339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 23. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
    Kallen RJ; Lee SK
    Pediatr Res; 1975 Sep; 9(9):705-9. PubMed ID: 53808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on coagulation, fibrinolysis, kallikrein-kinin and complement activation in systemic and pulmonary circulation during hip arthroplasty with acrylic cement.
    Dahl OE; Molnar I; Vinje A; Rø JS; Kierulf P; Andersen AB; Dalaker K; Prydz H
    Thromb Res; 1988 Jun; 50(6):875-84. PubMed ID: 3413734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward a better understanding of the hemodynamic effects of protamine and heparin interaction.
    Stefaniszyn HJ; Novick RJ; Salerno TA
    J Thorac Cardiovasc Surg; 1984 May; 87(5):678-86. PubMed ID: 6717047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between the renin-angiotensin and kallikrein-kinin systems of the blood during physical loading of hypertension patients].
    Svishchenko EP; Gomazkov OA; Zanozdra NS; Iakovlev AA; Chornoguz LS
    Kardiologiia; 1984 Mar; 24(3):79-83. PubMed ID: 6328097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteolytic and lysosomal enzymes in acute trauma-induced lung injury in sheep.
    Andreasson S; Smith L; Aasen AO; Andersen OK; Risberg B
    Acta Chir Scand; 1989; 155(1):1-6. PubMed ID: 2648713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K; Milne B; Salerno TA
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases.
    Barros NM; Puzer L; Tersariol IL; Oliva ML; Sampaio CA; Carmona AK; Motta G
    Biol Chem; 2004 Nov; 385(11):1087-91. PubMed ID: 15576330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of S-nitrosocysteine, an intravenous regional vasodilator.
    Stuesse DC; Giraud GD; Vlessis AA; Starr A; Trunkey DD
    J Thorac Cardiovasc Surg; 2001 Aug; 122(2):371-7. PubMed ID: 11479512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the plasma clotting, fibrinolytic, and kinin-kallikrein system in preterm infants with severe idiopathic respiratory distress syndrome.
    Brus F; van Oeveren W; Okken A; Oetomo SB
    Pediatr Res; 1994 Nov; 36(5):647-53. PubMed ID: 7877886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serine protease specificity for peptide chromogenic substrates.
    Mattler LE; Bang NU
    Thromb Haemost; 1977 Dec; 38(4):776-92. PubMed ID: 146272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the kinin-induced pathomechanisms in the development of ARDS by kallikrein inhibition in vivo.
    Thetter O; Hoffmann H; Siebeck M; Welter HF; Fritz H
    Prog Clin Biol Res; 1987; 236A():127-31. PubMed ID: 2441403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the kallikrein-kinin system in bullet wounding.
    Lewis DH; Bengtsson MB; Larsson J; Liljedahl SO
    Acta Chir Scand Suppl; 1979; 489():225-30. PubMed ID: 291259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined drug therapy in porcine endotoxemia. Hemodynamic and proteolytic effects of antagonists against histamine, serotonin and endorphin.
    Naess F; Roeise O; Stadaas JO; Aasen AO
    Eur Surg Res; 1990; 22(3):160-9. PubMed ID: 2265651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on pathological plasma proteolysis in severely burned patients using chromogenic peptide substrate assays: a preliminary report.
    Rund TE; Kierulf P; Godal HC; Aune S; Aasen AO
    Adv Exp Med Biol; 1984; 167():449-54. PubMed ID: 6231838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441).
    Högström H; Claeson G; Larsson-Backström C; Lundberg D; Wenngren E; Haglund U
    Acta Chir Scand; 1987 Mar; 153(3):161-4. PubMed ID: 3300117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decrease of plasma prekallikrein and kallikrein inhibitors during intravenous phlebography.
    Aronen HJ; Torstila I; Vahtera E; Suoranta HT
    Eur J Radiol; 1988 Feb; 8(1):30-3. PubMed ID: 2451609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.